AstraZeneca Halts Phase III Lung Cancer Trial as Drug Falls Short Against Keytruda — BigGo Finance
AstraZeneca has terminated a late-stage clinical trial for its experimental bispecific antibody volrustomig in metastatic non-small cell lung…
AstraZeneca gets EU nod for Etcamah in breast cancer | AZN SEC Filing
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant…
US FDA pushes back decision on Astrazeneca’s camizestrant
Drugmaker Astrazeneca said the US Food and Drug Administration had pushed back its decision on camizestrant after requesting…
How VEPPANU Approval Frames Expectations For AstraZeneca’s Camizestrant In ESR1 Disease
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…